Nuvation Bio Inc. (NUVB)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
NUVB Insider Trading Activity
NUVB Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $3,037,822 | 6 | 86 |
Sells | $162,883 | 1 | 14 |
Related Transactions
| Cui Xiangmin | director | 4 | $2.32M | 0 | $0 | $2.32M |
| BLICKENSTAFF KIM D | director | 1 | $500,089 | 0 | $0 | $500,089 |
| Mashal Robert | director | 1 | $220,000 | 0 | $0 | $220,000 |
| Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | 0 | $0 | 1 | $162,883 | $-162,883 |
About Nuvation Bio Inc.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an …
Insider Activity of Nuvation Bio Inc.
Over the last 12 months, insiders at Nuvation Bio Inc. have bought $3.04M and sold $162,883 worth of Nuvation Bio Inc. stock.
On average, over the past 5 years, insiders at Nuvation Bio Inc. have bought $6.57M and sold $22.18M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cui Xiangmin (director) — $2.32M. BLICKENSTAFF KIM D (director) — $500,089. Mashal Robert (director) — $220,000.
The last purchase of 100,000 shares for transaction amount of $220,000 was made by Mashal Robert (director) on 2024‑10‑08.
List of Insider Buy and Sell Transactions, Nuvation Bio Inc.
| 2024-11-11 | Sale | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | 56,361 0.0161% | $2.89 | $162,883 | -13.95% | |
| 2024-10-08 | Mashal Robert | director | 100,000 0.0359% | $2.20 | $220,000 | +12.56% | ||
| 2024-06-25 | Cui Xiangmin | director | 277,895 0.1098% | $2.97 | $825,348 | -11.35% | ||
| 2024-06-24 | Cui Xiangmin | director | 336,874 0.1354% | $2.98 | $1M | -10.00% | ||
| 2024-06-21 | Cui Xiangmin | director | 75,411 0.0321% | $3.00 | $226,233 | -11.48% | ||
| 2024-06-20 | Cui Xiangmin | director | 87,715 0.0372% | $2.99 | $262,268 | -10.89% | ||
| 2024-06-11 | BLICKENSTAFF KIM D | director | 172,189 0.071% | $2.90 | $500,089 | -3.86% | ||
| 2023-09-21 | NODELMAN OLEG | director | 53,000 0.0243% | $1.36 | $72,138 | +75.54% | ||
| 2023-09-20 | NODELMAN OLEG | director | 117,100 0.0542% | $1.36 | $159,490 | +79.63% | ||
| 2023-09-19 | NODELMAN OLEG | director | 5.14M 2.2462% | $1.26 | $6.46M | +81.82% | ||
| 2023-02-21 | NODELMAN OLEG | director | 53,000 0.016% | $1.36 | $72,138 | -20.39% | ||
| 2023-02-20 | NODELMAN OLEG | director | 117,100 0.0339% | $1.36 | $159,490 | -20.39% | ||
| 2023-02-19 | NODELMAN OLEG | director | 5.14M 1.3737% | $1.26 | $6.46M | -20.39% | ||
| 2022-12-05 | FALBERG KATHRYN E | director | 43,000 0.02% | $1.95 | $83,962 | -12.37% | ||
| 2022-12-02 | FALBERG KATHRYN E | director | 47,000 0.0215% | $1.98 | $93,187 | -15.00% | ||
| 2022-12-01 | FALBERG KATHRYN E | director | 84,959 0.0391% | $1.97 | $167,599 | -14.14% | ||
| 2022-11-30 | FALBERG KATHRYN E | director | 75,041 0.0336% | $1.85 | $139,088 | -10.99% | ||
| 2022-04-05 | Sale | Omega Fund V GP Manager, Ltd. | 2.5M 1.1241% | $5.60 | $14M | -59.30% | ||
| 2021-12-15 | Sale | Omega Fund V, L.P. | 10 percent owner | 500,000 0.2537% | $10.07 | $5.04M | -64.26% | |
| 2021-12-07 | Sale | Omega Fund V, L.P. | 10 percent owner | 1.4M 0.726% | $9.80 | $13.72M | -61.57% |
Insider Historical Profitability
| Cui Xiangmin | director | 2453131 0.7265% | $5.25M | 4 | 0 | |
| BLICKENSTAFF KIM D | director | 172189 0.051% | $368,484.46 | 1 | 0 | |
| Mashal Robert | director | 100000 0.0296% | $214,000.00 | 1 | 0 | |
| NODELMAN OLEG | director | 12674775 3.7535% | $27.12M | 12 | 2 | +4.57% |
| EcoR1 Panacea Holdings, LLC | 390000 0.1155% | $834,600.00 | 1 | 0 |
Historical Insider Profitability vs. Competitors
$3,596,906 | 112 | 13.42% | $635.29M | |
$36,510,315 | 95 | 8.95% | $609.56M | |
$7,929,017 | 58 | 21.56% | $787.18M | |
$97,176 | 41 | 42.84% | $802.16M | |
$94,912,877 | 34 | -7.15% | $622.67M |
NUVB Institutional Investors: Active Positions
| Increased Positions | 92 | +62.16% | 41M | +21.97% |
| Decreased Positions | 58 | -39.19% | 29M | -15.56% |
| New Positions | 27 | New | 5M | New |
| Sold Out Positions | 23 | Sold Out | 23M | Sold Out |
| Total Postitions | 182 | +22.97% | 199M | +6.41% |
NUVB Ownership Change vs Market
Institutional Investor Ownership
| Fmr Llc | $89,213.00 | 13.44% | 45.29M | +16M | +54.88% | 2024-12-31 |
| Decheng Capital Llc | $51,130.00 | 7.7% | 25.95M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $36,527.00 | 5.5% | 18.54M | +2M | +9.24% | 2024-12-31 |
| Vanguard Group Inc | $30,993.00 | 4.67% | 15.73M | +5M | +45.42% | 2024-12-31 |
| Omega Fund Management, Llc | $25,753.00 | 3.88% | 13.07M | 0 | 0% | 2024-12-31 |
| Octagon Capital Advisors Lp | $18,130.00 | 2.73% | 9.2M | -3M | -24.39% | 2024-12-31 |
| Laurion Capital Management Lp | $12,788.00 | 1.93% | 6.49M | +5M | +307.89% | 2024-12-31 |
| Geode Capital Management, Llc | $9,754.00 | 1.47% | 4.95M | +922,503 | +22.9% | 2024-12-31 |
| State Street Corp | $9,062.00 | 1.37% | 4.6M | +433,552 | +10.41% | 2024-12-31 |
| Mpm Bioimpact Llc | $8,203.00 | 1.24% | 4.16M | +4M | New | 2024-12-31 |